Percheron Therapeutics Discontinues American Depository Receipt Facility, Uplists to OTCQB

MT Newswires12/03 15:00

Just the Facts: Percheron Hits Milestone in Duchenne Drug Trial | ASX:PER, OTC:PERCF

Proactive Investors12/03 06:43

Percheron Therapeutics Advances Phase 2b Muscular Dystrophy Clinical Trial; Shares Down 3%

MT Newswires12/02 12:08

Percheron Therapeutics Price Target Cut 7% to A$0.25/Share by Wilsons

Dow Jones11/08 05:19

Percheron Therapeutics to Raise AU$13 Million via Share Placement; Shares Slump 35%

MT Newswires10/18 09:57

Percheron Therapeutics Ltd: Percheronは235万ドルの研究開発税制上の優遇措置を受けます

ASX10/08 06:37